Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes

Atherosclerotic CVD is a major cause of death in individuals with type 1 diabetes mellitus (T1DM). However, conventional risk factors do not fully account for the increased risk. This study aimed to investigate whether serum proteins associate with diabetes status and the occurrence of CVD in T1DM....

Full description

Saved in:
Bibliographic Details
Main Authors: Baohai Shao, Janet K. Snell-Bergeon, Ian H. de Boer, W. Sean Davidson, Karin E. Bornfeldt, Jay W. Heinecke
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752500001X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573240342478848
author Baohai Shao
Janet K. Snell-Bergeon
Ian H. de Boer
W. Sean Davidson
Karin E. Bornfeldt
Jay W. Heinecke
author_facet Baohai Shao
Janet K. Snell-Bergeon
Ian H. de Boer
W. Sean Davidson
Karin E. Bornfeldt
Jay W. Heinecke
author_sort Baohai Shao
collection DOAJ
description Atherosclerotic CVD is a major cause of death in individuals with type 1 diabetes mellitus (T1DM). However, conventional risk factors do not fully account for the increased risk. This study aimed to investigate whether serum proteins associate with diabetes status and the occurrence of CVD in T1DM. We used isotope dilution-MS/MS to quantify 28 serum proteins in 228 subjects participating in the prospective Coronary Artery Calcification in Type 1 Diabetes study. We used linear regression to analyze the association between serum protein levels and T1DM status using 47 healthy controls and 134 T1DM patients without CVD and Cox proportional hazards regression to assess their prediction for incident CVD by a case-cohort study using a subcohort of 145 T1DM subjects and a total of 47 CVD events. Of the 28 serum proteins studied, five of them—alpha-2-macroglobulin (A2M), apolipoprotein A-IV, apolipoprotein L1, insulin-like growth factor 2, and phospholipid transfer protein—were significantly associated with T1DM status, with A2M being 1.6-fold higher in T1DM. After adjusting for potential confounders, A2M independently predicted incident CVD, with a mean hazard ratio of 3.3 and 95% CI of 1.8–6.1. In our study, A2M showed the largest increase in serum levels when comparing patients with T1DM to control subjects. A2M also predicted incident CVD, suggesting that it could serve as both a marker and possibly a mediator of atherosclerosis in T1DM. These findings emphasize the importance of specific serum proteins in assessing and managing CVD risk in T1DM.
format Article
id doaj-art-b3292b81be634efc8c013b2fbd3d41a2
institution Kabale University
issn 0022-2275
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj-art-b3292b81be634efc8c013b2fbd3d41a22025-02-02T05:26:36ZengElsevierJournal of Lipid Research0022-22752025-02-01662100741Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetesBaohai Shao0Janet K. Snell-Bergeon1Ian H. de Boer2W. Sean Davidson3Karin E. Bornfeldt4Jay W. Heinecke5Department of Medicine, University of Washington, Seattle, WA; For correspondence: Baohai Shao.Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CODepartment of Medicine, University of Washington, Seattle, WADepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OHDepartment of Medicine, University of Washington, Seattle, WADepartment of Medicine, University of Washington, Seattle, WAAtherosclerotic CVD is a major cause of death in individuals with type 1 diabetes mellitus (T1DM). However, conventional risk factors do not fully account for the increased risk. This study aimed to investigate whether serum proteins associate with diabetes status and the occurrence of CVD in T1DM. We used isotope dilution-MS/MS to quantify 28 serum proteins in 228 subjects participating in the prospective Coronary Artery Calcification in Type 1 Diabetes study. We used linear regression to analyze the association between serum protein levels and T1DM status using 47 healthy controls and 134 T1DM patients without CVD and Cox proportional hazards regression to assess their prediction for incident CVD by a case-cohort study using a subcohort of 145 T1DM subjects and a total of 47 CVD events. Of the 28 serum proteins studied, five of them—alpha-2-macroglobulin (A2M), apolipoprotein A-IV, apolipoprotein L1, insulin-like growth factor 2, and phospholipid transfer protein—were significantly associated with T1DM status, with A2M being 1.6-fold higher in T1DM. After adjusting for potential confounders, A2M independently predicted incident CVD, with a mean hazard ratio of 3.3 and 95% CI of 1.8–6.1. In our study, A2M showed the largest increase in serum levels when comparing patients with T1DM to control subjects. A2M also predicted incident CVD, suggesting that it could serve as both a marker and possibly a mediator of atherosclerosis in T1DM. These findings emphasize the importance of specific serum proteins in assessing and managing CVD risk in T1DM.http://www.sciencedirect.com/science/article/pii/S002222752500001Xalpha-2-macroglobulinatherosclerosiscase-cohort designincident CVDCox proportional regressionmass spectrometry
spellingShingle Baohai Shao
Janet K. Snell-Bergeon
Ian H. de Boer
W. Sean Davidson
Karin E. Bornfeldt
Jay W. Heinecke
Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
Journal of Lipid Research
alpha-2-macroglobulin
atherosclerosis
case-cohort design
incident CVD
Cox proportional regression
mass spectrometry
title Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
title_full Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
title_fullStr Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
title_full_unstemmed Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
title_short Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes
title_sort elevated levels of serum alpha 2 macroglobulin associate with diabetes status and incident cvd in type 1 diabetes
topic alpha-2-macroglobulin
atherosclerosis
case-cohort design
incident CVD
Cox proportional regression
mass spectrometry
url http://www.sciencedirect.com/science/article/pii/S002222752500001X
work_keys_str_mv AT baohaishao elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes
AT janetksnellbergeon elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes
AT ianhdeboer elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes
AT wseandavidson elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes
AT karinebornfeldt elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes
AT jaywheinecke elevatedlevelsofserumalpha2macroglobulinassociatewithdiabetesstatusandincidentcvdintype1diabetes